Lifetech Pharmaceuticals (002393.SZ) released its first-half performance, with a net profit attributable to the parent company of 3.43 billion yuan, an increase of 235.04%.

Wisdom Finance APP News, Lifesense Pharmaceutical (002393.SZ) released its semi-annual report for 2025. The company's operating income was 732 million yuan, a decrease of 1.76% year-on-year. Net profit attributable to shareholders of the listed company was 343 million yuan, an increase of 235.04% year-on-year. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 104 million yuan, an increase of 5.09% year-on-year. Basic earnings per share was 1.33 yuan.